Verition Fund Management
TSVT

Verition Fund Management’s 2seventy bio TSVT Stock Holding History

Verition Fund Management’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-62,476
Closed -$309K – 3873
2025
Q1 		$309K Buy
+62,476
New +$198K ﹤0.01% 2852
2023
Q4 		– Sell
-56,786
Closed -$223K – 2689
2023
Q3 		$223K Buy
+56,786
New +$372K ﹤0.01% 1914

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Verition Fund Management's TSVT Position: Q2 2025 in Review

Verition Fund Management sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 62,476 shares — an estimated $309K sold.

Verition Fund Management first reported a position in TSVT in Q3 2023 and held it in 2 quarters. The position peaked at $309K in Q1 2025. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Verition Fund Management reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Verition Fund Management sold 62,476 2seventy bio shares in Q2 2025, an estimated $309K.
  • Verition Fund Management first reported a position in 2seventy bio in Q3 2023 and held it in 2 quarters.
  • Verition Fund Management's 2seventy bio position peaked at $309K in Q1 2025.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Verition Fund Management's 13F filing for Q2 2025, filed 14 Aug 2025.